PDRN (polydeoxyribonucleotide) solubility testing is an essential quality attribute evaluation for pharmaceutical, aesthetic, and cosmetic development programs utilizing this regenerative DNA-derived active ingredient. Our laboratory delivers comprehensive solubility characterization using validated analytical methods, including equilibrium solubility determination, pH-dependent profiling, and dissolution kinetics, to support formulation development, quality control, and regulatory submissions. With rigorous protocols and pharmacopoeial-grade instrumentation, we provide accurate, reproducible data that de-risk your PDRN product development pipeline.
Technical Overview
PDRN (polydeoxyribonucleotide) is a mixture of linear deoxyribonucleotide polymers, typically with molecular weights ranging from 50 to 1,500 kDa, derived from controlled extraction and purification of salmon milt or other fish gonad DNA. As an established regenerative active ingredient used in injectable aesthetics, wound healing therapies, and functional cosmetics, the solubility behavior of PDRN directly determines formulation feasibility, sterilization strategy, dosing accuracy, and long-term product stability.
PDRN in its sodium salt form is a highly hydrophilic polyanionic macromolecule that dissolves readily in water and aqueous buffers. However, apparent solubility can be influenced by molecular weight distribution, counter-ion composition, residual salts, pH, ionic strength, and temperature. A scientifically rigorous solubility assessment is therefore required to establish validated specifications for formulation development, quality control release testing, and regulatory documentation such as CMC sections of regulatory dossiers.
Our solubility testing program for PDRN combines classical equilibrium methods with modern instrumental quantification, delivering data packages suitable for internal R&D decision-making as well as submission-ready documentation.
Testing Samples
We accept a wide range of PDRN-containing sample types across the development lifecycle, from research-grade bulk material to finished drug products and cosmetic formulations.
PDRN Bulk Substance
Lyophilized or dried PDRN powder obtained from extraction and purification processes. Testing of bulk substance establishes the intrinsic solubility profile of the active moiety and supports incoming material qualification.
PDRN Sodium Salt and Derivatives
Sodium salt forms and chemically modified PDRN variants, including fractionated low-molecular-weight PDRN, which may exhibit solubility behavior distinct from the parent polymer.
PDRN Injectable Solutions
Ready-to-use sterile solutions and concentrates intended for intramuscular or subcutaneous administration, where solution clarity, reconstitution behavior, and concentration verification are critical quality attributes.
PDRN-Based Cosmetic Products
Serums, creams, ampoules, and mesotherapy solutions containing PDRN as a functional ingredient, assessed for solubility, clarity, and compatibility with cosmetic excipients.
PDRN Delivery Systems
PDRN-loaded hydrogels, lyophilized cakes for reconstitution, microneedle patches, and combination products where dissolution and release behavior must be characterized.
Testing Items
Our solubility testing panels are structured to cover all aspects of dissolution and solubility performance relevant to PDRN product development:
- Equilibrium (thermodynamic) solubility determination in water, saline, and physiological buffers
- Kinetic (apparent) solubility measurement for rapid screening studies
- pH-dependent solubility profiling across physiologically relevant pH ranges
- Temperature-dependent solubility studies (typically 4 °C to 60 °C)
- Dissolution rate and dissolution profile characterization
- Solubility in pharmaceutically relevant solvents and co-solvent systems
- Ionic strength and buffer composition effect evaluation
- Solution clarity and turbidity assessment against pharmacopoeial standards
- Reconstitution time testing for lyophilized PDRN preparations
- Solubilized concentration verification by orthogonal quantitative methods
Testing Methods
Solubility characterization is performed using validated, scientifically established methodologies appropriate to the sample type and study objectives.
Shake-Flask Equilibrium Method
The classical saturation shake-flask approach is applied as the reference method for thermodynamic solubility. Excess PDRN sample is equilibrated with the test medium under controlled temperature with continuous agitation, followed by separation of undissolved material by filtration or centrifugation and quantification of the saturated solution.
UV-Vis Spectrophotometry
Nucleotide content in saturated solutions is quantified by ultraviolet absorbance measurement at 260 nm using calibrated reference standards. This method provides sensitive and rapid concentration determination consistent with the spectral properties of DNA-derived polymers.
HPLC Quantification
High-performance liquid chromatography with UV detection is employed for orthogonal verification of dissolved PDRN concentration, particularly in complex matrices containing UV-absorbing excipients or impurities.
Turbidimetric and Visual Clarity Assessment
Solution turbidity is measured nephelometrically, and visual clarity is evaluated against pharmacopoeial reference suspensions. These tests are essential for injectable PDRN products, where particulate formation and opalescence must be controlled.
Dynamic Light Scattering
DLS analysis detects aggregate or colloid formation that may indicate apparent rather than true solubility, ensuring the integrity of reported solubility values for polymeric actives.
Dissolution Testing
Standard dissolution apparatus and controlled hydrodynamic conditions are used to characterize the dissolution rate and complete dissolution profile of PDRN powders and solid dosage forms.
Applications
Solubility testing data generated by our laboratory supports multiple stages of PDRN product development and commercialization:
- Preformulation screening and excipient compatibility studies for injectable PDRN products
- Formulation optimization for lyophilized powders intended for reconstitution
- Development of stable cosmetic serums and mesotherapy solutions
- Establishment of scientifically justified solubility specifications for quality control
- Batch release testing and stability program support for commercial products
- Regulatory documentation, including CMC data packages and drug master file support
- Comparative equivalence studies between PDRN suppliers or manufacturing processes
- Investigation of out-of-specification results related to precipitation or clarity deviations
FAQ
What is the typical aqueous solubility of PDRN?
PDRN sodium salt is freely soluble in water, with reported solubility values exceeding 50 mg/mL depending on molecular weight distribution and counter-ion composition. Because solubility is formulation- and grade-dependent, experimental determination for each specific material is strongly recommended rather than relying on literature values.
Why is solubility testing important for injectable PDRN products?
For injectable products, solubility directly affects solution clarity, sterility assurance during filtration, dosing accuracy, and physical stability during storage. Solubility testing ensures that the formulated concentration remains safely below saturation under all anticipated storage and use conditions.
What sample quantity is required for testing?
Typical equilibrium solubility studies require approximately 100 to 500 mg of PDRN bulk material depending on the number of media and conditions tested. Finished product samples generally require 10 to 20 units per test condition. Custom protocols can be adapted for limited-quantity research samples.
Which regulatory standards apply to the testing methods?
Our solubility methods are developed in alignment with ICH Q2(R2) analytical validation principles and relevant pharmacopoeial general chapters for solubility determination, dissolution testing, and solution clarity evaluation.
What is the typical turnaround time?
Standard aqueous solubility and clarity studies are typically completed within 10 to 15 business days. Comprehensive pH- and temperature-dependent profiling programs, including method validation and full documentation packages, generally require 3 to 5 weeks depending on study scope.
Can solubility testing be combined with other PDRN characterization services?
Yes. Solubility testing is frequently combined with molecular weight distribution analysis, purity and identity testing, endotoxin testing, and residual solvent analysis to provide a complete characterization package supporting regulatory submissions and supplier qualification.